Content deleted Content added
No edit summary |
No edit summary |
||
Line 27:
== Promoting Health Care Outcomes ==
The interprofessional team must be aware of the clinical features of patients with complement deficiency or immunodeficiency, and refer them to allergist/immunologists when necessary. Infection prevention and treatment of infections are key for complement deficiencies.<ref>https://primaryimmune.org/about-primary-immunodeficiencies/specific-disease-types/complement-deficiencies#:~:text=Treatment%20of%20Complement%20Deficiencies&text=Currently%2C%20there%20are%20no%20specific,of%20patients%20with%20these%20deficiencies.</ref>
Patient organizations build public awareness and support research to improve patients' lives. Patient organizations provide access to information, resources, and support.
== Conclusion ==
Photosensitive patients with C2 type I deficiency have poor prognosis. C2 type I deficiency is caused by a 28-base pair gene deletion, resulting in premature termination codon and lack of C2 protein.Patients with LE associated with complement C4 or C2 deficiencies have a better prognosis than those without inherited deficiencies
== References ==
| |||